PA subunit of RNA polymerase as a promising target for anti-influenza virus agents

Related Experiment Video

Updated: Jul 7, 2026

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

Misako Nakazawa1, Shin-etsu Kadowaki, Izumi Watanabe

  • 1Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., Tochigi 329-0114, Japan. misako.nakazawa@mb.kyorin-pharm.co.jp

Antiviral Research
|February 9, 2008
PubMed

Insights

The influenza virus RNA polymerase inhibitor L-742,001 effectively reduces viral RNA accumulation and replication. This drug targets the PA subunit, showing promise as a novel anti-influenza agent.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Influenza virus RNA polymerase is essential for viral replication.
  • Targeting viral enzymes is a key strategy for developing antiviral therapies.

Purpose of the Study:

  • To investigate the antiviral activity and mechanism of the RNA polymerase inhibitor L-742,001 against influenza virus.
  • To identify the specific viral component targeted by L-742,001.

Main Methods:

  • Use of small interfering RNA (siRNA) against viral RNA polymerase.
  • Treatment of infected cells with L-742,001 and zanamivir.
  • Analysis of viral RNA accumulation and virus re-growth.
  • Generation and characterization of drug-resistant influenza virus mutants.

Main Results:

  • L-742,001 reduced viral RNA accumulation and inhibited virus re-growth.
  • L-742,001-resistant mutants exhibited a Thr-20 to Ala substitution in the PA subunit.
  • The drug demonstrated a unique resistance profile, distinct from neuraminidase inhibitors.
  • L-742,001 retained activity against zanamivir-resistant strains.

Conclusions:

  • L-742,001 likely targets the PA subunit of the influenza virus RNA polymerase.
  • The PA subunit represents a promising target for novel anti-influenza virus agents.
  • L-742,001 exhibits a unique antiviral profile with potential therapeutic value.

More Related Videos

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells11:20

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells

Published on: June 3, 2012

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Bacterial RNA Polymerase00:43

Bacterial RNA Polymerase

Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...